Research Notes: FDA warning Elmiron Pigmentary Maculopathy

A curated reading list of authoritative medical research, drug-safety databases, and focused analysis for researchers, patients, and advocates.

Primary topic reference

Understanding FDA warning Elmiron Pigmentary Maculopathy

In-depth context and analysis on this topic for researchers and advocates.

Centers for Disease Control and Prevention (CDC)

Reference: Centers for Disease Control and Prevention (CDC)

Authoritative source for clinical, regulatory, and public-health background reading.

European Medicines Agency (EMA)

Reference: European Medicines Agency (EMA)

Authoritative source for clinical, regulatory, and public-health background reading.